|
English
|
正體中文
|
简体中文
|
2831143
|
|
???header.visitor??? :
33138315
???header.onlineuser??? :
1218
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"mok tony shu kam"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2016-10 |
A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma
|
Mok, Tony Shu Kam; Geater, Sarayut Lucien; Su, Wu-Chou; Tan, Eng-Huat; Yang, James Chi-Hsin; Chang, Gee-Chen; Han, May; Komarnitsky, Philip; Payumo, Francis; Garrus, Jennifer E.; Close, Sandra; Park, Keunchil |
| 國立臺灣大學 |
2015 |
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|
Yang, James C-H; Sequist, Lecia V.; Geater, Sarayut Lucien; Tsai, Chun-Ming; Mok, Tony Shu Kam; Schuler, Martin; Yamamoto, Nobuyuki; Yu, Chong-Jen; Ou, Sai-Hong I.; Zhou, Caicun; Massey, Daniel; Zazulina, Victoria; Wu, Yi-Long; 楊志新; 余忠仁 |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
